RSNA 2024: Transforming Breast Health through AI
The Radiological Society of North America (RSNA) 2024 Annual Meeting once again set the stage for iCAD’s impactful presence, showcasing the latest advancements in breast imaging and artificial intelligence (AI). With over 40,000 attendees—an 18% increase from the previous year—and 715 exhibitors, the event underscored the rapidly growing focus on...
At ECR 2024, iCAD showed strong collaboration at European Congress: A Recap of Key Events
At this year’s European Congress of Radiology (ECR 2024) in Vienna, Austria, iCAD demonstrated how the ProFound AI Breast Health Suite enables medical providers to detect cancer earlier and more accurately, improving patient outcomes. The demonstrations highlighted the new release of its AI-powered ProFound Detection workflow solution, while showcasing its...
iCAD’s Innovative Leadership in Mammography AI Shined at RSNA 2023: A Recap of Key Events
Attendees at this year’s Radiological Society of North America (RSNA) 2023 Annual Meeting witnessed iCAD’s prominent presence, showcasing groundbreaking advancements in the field of breast imaging and artificial intelligence (AI). iCAD, a global medical technology leader in innovative cancer detection solutions, made headlines with new clinical data, shared exciting partnership...
RSNA 2018: Artificial Intelligence Dominates the Show
RSNA 2018 is a wrap, but the buzz continues, and we want to thank everyone that visited with iCAD during the show that had the opportunity to experience our ProFound AI solution for breast tomosynthesis and those we have met with since the show closed. As you can imagine, lots...